Researchers say a 23andMe study tied GLP1R and GIPR variants to nausea and vomiting, but nobody has checked how genes and microbiome combine to shape tolerance.
Recap by typeshit. Full story at Bioengineer.org.
Half of people with diabetes for 10 years or more said they were very satisfied on a GLP-1. Gen Z users were the most likely to stop and restart treatment.
64% of current users faced some negative reaction. Men, BIPOC respondents and the newly diagnosed reported it most, while 69% of boomers felt none.
The workflow uses glutathione or sulfatase triggers to target organelles and tumors in mice, and the authors say it takes 92 to 115 days to run.
A University of Pennsylvania mouse study found on-off GLP-1 use left mice 20 per cent heavier than those kept on the drug, and doctors warn human effects are unknown.
A Facebook post links to a story saying curiosity about a particular GLP-1 side effect traces back to speculation online. The side effect isn't named.
NewBeauty talks with New York plastic surgeon Dr. Anna Steve about how common GLP-1 use has become among the people coming to her practice.
Loading…